|
||||||
|
 | |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
|
Gene: ENSG00000135480 |
Summary for KRT7 |
 Gene summary |
| Gene information | Ensembl ID | ENSG00000135480 | Gene symbol | KRT7 |
| Gene name | keratin 7 | |
| HGNC | 6445 | |
| Entrez ID | 3855 | |
| Gene type | protein_coding | |
| Synonyms | KRT7|K7|CK7|CK-7|K2C7|SCL | |
| UniProtAcc | P08729 |
| Drugs associated with this gene(DrugBank). |
| Gene ID | Gene Symbol | Drug ID | Drug Name | Drug Type |
| Cancer therapeutic drugs associated with this gene(NCI). |
| Gene ID | Gene Name | Drug ID | Drug Name | Drug Type | Cancer |
Top |
Structure and expression level for KRT7 |
| AS events and RNA A-to-I editing events of the gene in TCGA based on Genvode V22 structure. ∗For more information on exon skipping events please check the ExonskipDB database. ∗For more information on exon skipping events please check the CAeditome database. |
 |
| Landscape of gene expressions across multiple cancer types. |
 |
| Differentially expressed gene analysis between tumor male and tumor female samples. |
 |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
| KRT7 | 1.91e+03 | 1.05e+00 | 1.97e-01 | 5.33e+00 | 9.88e-08 | 3.46e-06 | KIRC |
| KRT7 | 2.81e+03 | -1.72e+00 | 2.77e-01 | -6.21e+00 | 5.38e-10 | 4.63e-08 | LIHC |
| KRT7 | 3.95e+02 | 1.27e+00 | 2.59e-01 | 4.91e+00 | 9.16e-07 | 4.85e-05 | SARC |
| Differentially expressed gene analysis between tumor male and normal male samples. |
 |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
| KRT7 | 1.12e+05 | 1.99e+00 | 5.51e-01 | 3.61e+00 | 3.10e-04 | 1.20e-03 | BLCA |
| KRT7 | 2.90e+04 | 2.02e+00 | 3.72e-01 | 5.44e+00 | 5.38e-08 | 2.36e-07 | KIRP |
| KRT7 | 2.10e+04 | 3.02e+00 | 5.12e-01 | 5.89e+00 | 3.89e-09 | 4.82e-08 | CHOL |
| Differentially expressed gene analysis between tumor female and normal female samples. |
 |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
| KRT7 | 4.65e+03 | 1.45e+00 | 6.18e-01 | 2.34e+00 | 1.92e-02 | 3.51e-02 | LIHC |
| KRT7 | 2.09e+02 | 2.46e+00 | 5.46e-01 | 4.51e+00 | 6.48e-06 | 4.47e-05 | READ |
Top |
Sex-biased somatic mutation for KRT7 |
| ∗For more information on exon skipping events please check the ExonskipDB database. |
| Gene ID | Cancer Type | Hugo Symbol | Male | Female | pval | or | ci.up | ci.low | adjPval |
Top |
DNA methylation with beta values for KRT7 |
| Landscape of DNA methylation across multiple cancer types. |
 |
| Differentially expressed CpG sites between male tumor and female tumor patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| BRCA | cg25313172 | chr12:52233488 | CGI:chr12:52233009-52233793 | promoter,exon,CDS,gene body | 1.80e-01 | 4.26e-01 | -1.96e+00 | 4.95e-02 | 4.97e-02 | -2.46e-01 |
| BRCA | cg14482313 | chr12:52233105 | CGI:chr12:52233009-52233793 | promoter,exon,gene body | 1.85e-01 | 4.48e-01 | -1.98e+00 | 4.80e-02 | 4.92e-02 | -2.63e-01 |
| BRCA | cg14537533 | chr12:52233120 | CGI:chr12:52233009-52233793 | UTR,promoter,exon,gene body | 1.84e-01 | 4.73e-01 | -2.05e+00 | 3.99e-02 | 4.59e-02 | -2.89e-01 |
| BRCA | cg09670128 | chr12:52233263 | CGI:chr12:52233009-52233793 | UTR,promoter,exon,gene body | 1.75e-01 | 5.07e-01 | -2.27e+00 | 2.34e-02 | 3.71e-02 | -3.33e-01 |
| BRCA | cg22958090 | chr12:52233654 | CGI:chr12:52233009-52233793 | promoter,gene body | 4.20e-01 | 6.84e-01 | -2.21e+00 | 2.71e-02 | 3.93e-02 | -2.63e-01 |
| BRCA | cg07007400 | chr12:52233047 | CGI:chr12:52233009-52233793 | promoter,exon,gene body | 2.56e-01 | 4.98e-01 | -2.12e+00 | 3.41e-02 | 4.32e-02 | -2.43e-01 |
| BRCA | cg06153634 | chr12:52233792 | CGI:chr12:52233009-52233793 | promoter,gene body | 2.35e-01 | 4.38e-01 | -2.26e+00 | 2.36e-02 | 3.72e-02 | -2.04e-01 |
| BRCA | cg14059257 | chr12:52234321 | CGI:chr12:52233009-52233793 | promoter,gene body | 4.74e-01 | 6.38e-01 | -2.23e+00 | 2.54e-02 | 3.83e-02 | -1.64e-01 |
| BLCA | cg14537533 | chr12:52233120 | CGI:chr12:52233009-52233793 | UTR,promoter,exon,gene body | 2.45e-01 | 1.41e-01 | 3.64e+00 | 2.73e-04 | 1.70e-03 | 1.04e-01 |
| BLCA | cg22958090 | chr12:52233654 | CGI:chr12:52233009-52233793 | promoter,gene body | 3.82e-01 | 2.56e-01 | 3.73e+00 | 1.93e-04 | 1.25e-03 | 1.27e-01 |
| KIRP | cg22958090 | chr12:52233654 | CGI:chr12:52233009-52233793 | promoter,gene body | 5.48e-01 | 3.40e-01 | 4.42e+00 | 9.76e-06 | 9.42e-05 | 2.08e-01 |
| KIRP | cg25881535 | chr12:52232113 | CGI:chr12:52233009-52233793 | promoter | 5.82e-01 | 4.76e-01 | 3.04e+00 | 2.40e-03 | 8.72e-03 | 1.06e-01 |
| KIRP | cg14059257 | chr12:52234321 | CGI:chr12:52233009-52233793 | promoter,gene body | 6.69e-01 | 5.41e-01 | 4.14e+00 | 3.53e-05 | 3.07e-04 | 1.28e-01 |
| ESCA | cg07967679 | chr12:52233030 | CGI:chr12:52233009-52233793 | promoter,gene body | 4.60e-01 | 3.47e-01 | 2.12e+00 | 3.37e-02 | 4.53e-02 | 1.13e-01 |
| ESCA | cg14482313 | chr12:52233105 | CGI:chr12:52233009-52233793 | promoter,exon,gene body | 3.98e-01 | 2.69e-01 | 1.97e+00 | 4.89e-02 | 4.97e-02 | 1.30e-01 |
| ESCA | cg14537533 | chr12:52233120 | CGI:chr12:52233009-52233793 | UTR,promoter,exon,gene body | 4.16e-01 | 2.83e-01 | 2.14e+00 | 3.25e-02 | 4.49e-02 | 1.33e-01 |
| ESCA | cg09670128 | chr12:52233263 | CGI:chr12:52233009-52233793 | UTR,promoter,exon,gene body | 4.48e-01 | 2.94e-01 | 1.99e+00 | 4.62e-02 | 4.91e-02 | 1.54e-01 |
| ESCA | cg08975803 | chr12:52233034 | CGI:chr12:52233009-52233793 | promoter,gene body | 4.31e-01 | 3.28e-01 | 2.10e+00 | 3.54e-02 | 4.59e-02 | 1.03e-01 |
| ACC | cg22813430 | chr12:52232643 | CGI:chr12:52233009-52233793 | promoter,exon,gene body | 4.85e-01 | 6.41e-01 | -2.14e+00 | 3.25e-02 | 4.27e-02 | -1.56e-01 |
| Differentially expressed CpG sites between male tumor and male normal patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| KIRC | cg22813430 | chr12:52232643 | CGI:chr12:52233009-52233793 | promoter,exon,gene body | 2.47e-01 | 1.27e-01 | 5.73e+00 | 1.03e-08 | 7.42e-08 | 1.20e-01 |
| KIRC | cg08975803 | chr12:52233034 | CGI:chr12:52233009-52233793 | promoter,gene body | 2.38e-01 | 1.28e-01 | 6.00e+00 | 1.94e-09 | 1.98e-08 | 1.10e-01 |
| LUAD | cg10369242 | chr12:52231702 | CGI:chr12:52233009-52233793 | promoter | 4.34e-01 | 5.45e-01 | -3.40e+00 | 6.84e-04 | 1.41e-03 | -1.11e-01 |
| LUSC | cg07967679 | chr12:52233030 | CGI:chr12:52233009-52233793 | promoter,gene body | 4.74e-01 | 1.59e-01 | 3.58e+00 | 3.50e-04 | 1.33e-03 | 3.15e-01 |
| LUSC | cg25313172 | chr12:52233488 | CGI:chr12:52233009-52233793 | promoter,exon,CDS,gene body | 4.07e-01 | 5.88e-02 | 3.62e+00 | 2.98e-04 | 1.21e-03 | 3.49e-01 |
| LUSC | cg22813430 | chr12:52232643 | CGI:chr12:52233009-52233793 | promoter,exon,gene body | 3.68e-01 | 1.88e-01 | 2.92e+00 | 3.55e-03 | 6.33e-03 | 1.80e-01 |
| LUSC | cg14482313 | chr12:52233105 | CGI:chr12:52233009-52233793 | promoter,exon,gene body | 4.07e-01 | 7.51e-02 | 2.97e+00 | 2.96e-03 | 5.54e-03 | 3.32e-01 |
| LUSC | cg14537533 | chr12:52233120 | CGI:chr12:52233009-52233793 | UTR,promoter,exon,gene body | 4.49e-01 | 3.07e-02 | 3.50e+00 | 4.58e-04 | 1.57e-03 | 4.18e-01 |
| LUSC | cg09670128 | chr12:52233263 | CGI:chr12:52233009-52233793 | UTR,promoter,exon,gene body | 4.58e-01 | 2.44e-02 | 3.94e+00 | 8.22e-05 | 6.46e-04 | 4.33e-01 |
| LUSC | cg22958090 | chr12:52233654 | CGI:chr12:52233009-52233793 | promoter,gene body | 6.72e-01 | 1.82e-01 | 3.54e+00 | 4.04e-04 | 1.45e-03 | 4.90e-01 |
| LUSC | cg25881535 | chr12:52232113 | CGI:chr12:52233009-52233793 | promoter | 6.33e-01 | 4.92e-01 | 2.76e+00 | 5.78e-03 | 9.10e-03 | 1.41e-01 |
| LUSC | cg08975803 | chr12:52233034 | CGI:chr12:52233009-52233793 | promoter,gene body | 4.41e-01 | 1.63e-01 | 3.58e+00 | 3.38e-04 | 1.31e-03 | 2.78e-01 |
| LUSC | cg07007400 | chr12:52233047 | CGI:chr12:52233009-52233793 | promoter,exon,gene body | 4.72e-01 | 1.22e-01 | 3.74e+00 | 1.81e-04 | 9.20e-04 | 3.50e-01 |
| LUSC | cg06153634 | chr12:52233792 | CGI:chr12:52233009-52233793 | promoter,gene body | 3.86e-01 | 1.35e-01 | 3.90e+00 | 9.81e-05 | 6.92e-04 | 2.51e-01 |
| LUSC | cg14059257 | chr12:52234321 | CGI:chr12:52233009-52233793 | promoter,gene body | 6.14e-01 | 4.28e-01 | 2.88e+00 | 3.94e-03 | 6.84e-03 | 1.86e-01 |
| BLCA | cg22813430 | chr12:52232643 | CGI:chr12:52233009-52233793 | promoter,exon,gene body | 1.71e-01 | 2.94e-01 | -3.29e+00 | 1.01e-03 | 2.29e-03 | -1.23e-01 |
| BLCA | cg22958090 | chr12:52233654 | CGI:chr12:52233009-52233793 | promoter,gene body | 2.56e-01 | 3.65e-01 | -2.14e+00 | 3.23e-02 | 3.56e-02 | -1.09e-01 |
| BLCA | cg14059257 | chr12:52234321 | CGI:chr12:52233009-52233793 | promoter,gene body | 3.37e-01 | 4.90e-01 | -3.04e+00 | 2.35e-03 | 4.46e-03 | -1.53e-01 |
| LIHC | cg14059257 | chr12:52234321 | CGI:chr12:52233009-52233793 | promoter,gene body | 5.76e-01 | 4.32e-01 | 3.75e+00 | 1.77e-04 | 3.41e-04 | 1.44e-01 |
| KIRP | cg22958090 | chr12:52233654 | CGI:chr12:52233009-52233793 | promoter,gene body | 3.40e-01 | 6.03e-01 | -2.64e+00 | 8.28e-03 | 1.09e-02 | -2.62e-01 |
| KIRP | cg25881535 | chr12:52232113 | CGI:chr12:52233009-52233793 | promoter | 4.76e-01 | 5.93e-01 | -2.58e+00 | 9.87e-03 | 1.27e-02 | -1.17e-01 |
| ESCA | cg09670128 | chr12:52233263 | CGI:chr12:52233009-52233793 | UTR,promoter,exon,gene body | 2.94e-01 | 5.41e-02 | 2.47e+00 | 1.34e-02 | 3.76e-02 | 2.40e-01 |
| Differentially expressed CpG sites between female tumor and female normal patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| BRCA | cg07967679 | chr12:52233030 | CGI:chr12:52233009-52233793 | promoter,gene body | 2.69e-01 | 1.43e-01 | 4.94e+00 | 7.98e-07 | 1.50e-06 | 1.26e-01 |
| BRCA | cg22813430 | chr12:52232643 | CGI:chr12:52233009-52233793 | promoter,exon,gene body | 3.24e-01 | 1.97e-01 | 6.32e+00 | 2.60e-10 | 6.61e-10 | 1.27e-01 |
| BRCA | cg22958090 | chr12:52233654 | CGI:chr12:52233009-52233793 | promoter,gene body | 4.20e-01 | 2.96e-01 | 2.34e+00 | 1.91e-02 | 2.06e-02 | 1.24e-01 |
| BRCA | cg10369242 | chr12:52231702 | CGI:chr12:52233009-52233793 | promoter | 3.23e-01 | 5.09e-01 | -8.50e+00 | 1.85e-17 | 8.14e-17 | -1.86e-01 |
| BRCA | cg08975803 | chr12:52233034 | CGI:chr12:52233009-52233793 | promoter,gene body | 2.66e-01 | 1.60e-01 | 4.42e+00 | 9.86e-06 | 1.65e-05 | 1.06e-01 |
| BRCA | cg07007400 | chr12:52233047 | CGI:chr12:52233009-52233793 | promoter,exon,gene body | 2.56e-01 | 1.44e-01 | 3.38e+00 | 7.22e-04 | 9.66e-04 | 1.12e-01 |
| KIRC | cg07007400 | chr12:52233047 | CGI:chr12:52233009-52233793 | promoter,exon,gene body | 2.26e-01 | 1.20e-01 | 3.01e+00 | 2.58e-03 | 7.43e-03 | 1.06e-01 |
| KIRC | cg14059257 | chr12:52234321 | CGI:chr12:52233009-52233793 | promoter,gene body | 6.84e-01 | 5.53e-01 | 2.82e+00 | 4.84e-03 | 1.08e-02 | 1.30e-01 |
| HNSC | cg06153634 | chr12:52233792 | CGI:chr12:52233009-52233793 | promoter,gene body | 4.02e-01 | 2.80e-01 | 2.36e+00 | 1.81e-02 | 2.60e-02 | 1.21e-01 |
| HNSC | cg14059257 | chr12:52234321 | CGI:chr12:52233009-52233793 | promoter,gene body | 6.77e-01 | 5.20e-01 | 2.73e+00 | 6.41e-03 | 1.49e-02 | 1.57e-01 |
| LIHC | cg25313172 | chr12:52233488 | CGI:chr12:52233009-52233793 | promoter,exon,CDS,gene body | 2.03e-01 | 4.80e-02 | 2.79e+00 | 5.35e-03 | 8.47e-03 | 1.55e-01 |
| LIHC | cg22813430 | chr12:52232643 | CGI:chr12:52233009-52233793 | promoter,exon,gene body | 3.82e-01 | 1.92e-01 | 3.31e+00 | 9.46e-04 | 2.16e-03 | 1.90e-01 |
| LIHC | cg08975803 | chr12:52233034 | CGI:chr12:52233009-52233793 | promoter,gene body | 2.95e-01 | 1.70e-01 | 2.95e+00 | 3.19e-03 | 5.63e-03 | 1.25e-01 |
| LIHC | cg06153634 | chr12:52233792 | CGI:chr12:52233009-52233793 | promoter,gene body | 2.79e-01 | 1.46e-01 | 2.79e+00 | 5.35e-03 | 8.47e-03 | 1.33e-01 |
| KIRP | cg14537533 | chr12:52233120 | CGI:chr12:52233009-52233793 | UTR,promoter,exon,gene body | 1.77e-01 | 2.37e-02 | 2.49e+00 | 1.29e-02 | 2.00e-02 | 1.53e-01 |
Top |
Exon skipping events with PSI in TCGA for KRT7 |
| ∗Please access ExonSkipDB for exon skipping annotation. |
| Landscape of exon skipping events across multiple cancer types. |
 |
| Differentially expressed exon skipping events between male tumor and female tumor patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
| Differentially expressed exon skipping events between male tumor and male normal patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
| Differentially expressed exon skipping events between female tumor and female normal patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
Top |
RNA A-to-I editing events in TCGA for KRT7 |
| ∗Please access CAeditome for RNA editing annotation. |
| Differentially expressed RNA editing events between male tumor and female tumor patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
| Differentially expressed RNA editing events between male tumor and male normal patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
| Differentially expressed RNA editing events between female tumor and female normal patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
| Protein coding RNA editing(s). |
| Editing Position | Variant Type | Gene Symbol | Transcript ID | NTchange | AAchange |
Top |
Sex-biased TF-Gene network for KRT7 |
| TFs related to KRT7. ∗The female-biased TF-gene edges were identified if Female_Edge_threshold>0.98 and Male_Edge_threshold<=0.98. ∗The male-biased TF-gene edges were identified if Male_Edge_threshold>0.98 and Female_Edge_threshold<=0.98. |
| Cancer Type | TF | Target Gene | Male Edge Score | Male Edge Threshold | Female Edge Score | Female Edge Threshold | Type |
| KRT7 related gene. ∗Only the gene encode TF might with this result. ∗For more information please check Sex-biased TF-Coding gene network. |
Top |
Sex-biased RBP-ES network for KRT7 |
| RBPs related to ES in KRT7. ∗The female-biased RBP-ES edges were identified if Female_Edge_threshold>0.98 and Male_Edge_threshold<=0.98. ∗The male-biased RBP-ES edges were identified if Male_Edge_threshold>0.98 and Female_Edge_threshold<=0.98. |
 |
| Cancer Type | RBP | Target ES | Male Edge Score | Male Edge Threshold | Female Edge Score | Female Edge Threshold | Type |
| LUAD | SAMD4A | exon_skip_82832 | 6.51e+00 | 2.29e-03 | 6.99e+00 | 9.84e-01 | Female-biased |
| BRCA | SAMD4A | exon_skip_82822 | 5.33e+00 | 2.61e-04 | 7.36e+00 | 9.89e-01 | Female-biased |
| KRT7 related ES. ∗Only the gene encode RBP might with this result. ∗For more information please check Sex-biased RBP-ES network in cancer. |
Top |
Sex-biased CeRNA regulation of gene |
| Sex-biased CeRNA regulation of gene. |
| Gene ID | ceRNA(lncRNA-miRNA-mRNA) | Group | Cancer Type |
Top |
Sex-biased eQTL regulation of gene |
| Sex-biased eQTL regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| eQTL | Description |
| Male-specific eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Effect Score | FDR | Cancer Type | Biased Type |
| rs73094387 | chr12:44476322:T:C | - | 0.139665095746637 | 5.82945039508888e-05 | SARC | Female-baised eQTL |
| rs55956897 | chr12:44494879:C:G | - | 0.139665095746637 | 5.82945039508888e-05 | SARC | Female-baised eQTL |
| rs75918019 | chr12:46821248:A:G | - | 0.124043988798063 | 0.000276202717771828 | SARC | Female-baised eQTL |
| rs11170104 | chr12:52371977:G:T | - | 0.122659999714785 | 0.000399332946375912 | SARC | Female-baised eQTL |
| rs10876281 | chr12:52372779:G:A | - | 0.122659999714785 | 0.000399332946375912 | SARC | Female-baised eQTL |
| rs2279906 | chr12:52377477:C:A | - | 0.122503988856142 | 0.000405283174108527 | SARC | Female-baised eQTL |
| rs10876282 | chr12:52374456:G:A | - | 0.122499206895262 | 0.000409206590811863 | SARC | Female-baised eQTL |
| rs10876283 | chr12:52375504:T:C | - | 0.122499206895262 | 0.000409206590811863 | SARC | Female-baised eQTL |
| rs146175635 | chr12:44450563:G:A | - | 0.108313727164026 | 0.00287089183182985 | SARC | Female-baised eQTL |
| rs55923007 | chr12:44453220:C:A | - | 0.108313727164026 | 0.00287089183182985 | SARC | Female-baised eQTL |
| rs112200836 | chr12:44455362:T:C | - | 0.108313727164026 | 0.00287089183182985 | SARC | Female-baised eQTL |
| rs12304369 | chr12:46980529:T:G | - | 0.101391244344215 | 0.00289209753314148 | SARC | Female-baised eQTL |
| rs149847840 | chr12:44399911:T:C | - | 0.108270550990853 | 0.00292993371483067 | SARC | Female-baised eQTL |
| rs75635157 | chr12:44401094:A:T | - | 0.108270550990853 | 0.00292993371483067 | SARC | Female-baised eQTL |
| rs148315743 | chr12:44343159:G:A | - | 0.107982389336743 | 0.00305561366426825 | SARC | Female-baised eQTL |
| rs7310993 | chr12:44345889:A:G | - | 0.107982389336743 | 0.00305561366426825 | SARC | Female-baised eQTL |
| rs17094494 | chr12:44347984:A:T | - | 0.107982389336743 | 0.00305561366426825 | SARC | Female-baised eQTL |
| rs142552068 | chr12:44354069:A:G | - | 0.107982389336743 | 0.00305561366426825 | SARC | Female-baised eQTL |
| rs117447371 | chr12:44361019:A:G | - | 0.107982389336743 | 0.00305561366426825 | SARC | Female-baised eQTL |
| rs7310784 | chr12:44361727:C:T | - | 0.107982389336743 | 0.00305561366426825 | SARC | Female-baised eQTL |
| rs150360937 | chr12:44367898:C:A | - | 0.107982389336743 | 0.00305561366426825 | SARC | Female-baised eQTL |
| rs79248757 | chr12:44367978:C:A | - | 0.107982389336743 | 0.00305561366426825 | SARC | Female-baised eQTL |
| rs2068103 | chr12:44371527:T:G | - | 0.107982389336743 | 0.00305561366426825 | SARC | Female-baised eQTL |
| rs77777887 | chr12:46787098:A:T | - | 0.102057059344838 | 0.00401600031579951 | SARC | Female-baised eQTL |
| rs79297632 | chr12:46787542:G:C | - | 0.102057059344838 | 0.00401600031579951 | SARC | Female-baised eQTL |
| rs76191003 | chr12:46788748:C:T | - | 0.102057059344838 | 0.00401600031579951 | SARC | Female-baised eQTL |
| rs17602430 | chr12:46791735:C:T | - | 0.102057059344838 | 0.00401600031579951 | SARC | Female-baised eQTL |
| rs75590689 | chr12:46791948:G:C | - | 0.102057059344838 | 0.00401600031579951 | SARC | Female-baised eQTL |
| rs79476006 | chr12:46793911:G:A | - | 0.102057059344838 | 0.00401600031579951 | SARC | Female-baised eQTL |
| rs76241059 | chr12:46794650:C:G | - | 0.102057059344838 | 0.00401600031579951 | SARC | Female-baised eQTL |
| rs76943648 | chr12:46796695:T:C | - | 0.102057059344838 | 0.00401600031579951 | SARC | Female-baised eQTL |
| rs78802502 | chr12:46796900:G:A | - | 0.102035085422098 | 0.00406369540329843 | SARC | Female-baised eQTL |
| rs78855118 | chr12:46797709:C:T | - | 0.102035085422098 | 0.00406369540329843 | SARC | Female-baised eQTL |
| rs74832478 | chr12:46799365:G:T | - | 0.102035085422098 | 0.00406369540329843 | SARC | Female-baised eQTL |
| rs10506248 | chr12:44390448:A:C | - | 0.102696591044022 | 0.00527377650273184 | SARC | Female-baised eQTL |
| rs73094339 | chr12:44425459:G:C | - | 0.102488140463283 | 0.00545117551646823 | SARC | Female-baised eQTL |
| rs73094354 | chr12:44428966:T:C | - | 0.102488140463283 | 0.00545117551646823 | SARC | Female-baised eQTL |
| rs7958792 | chr12:44436303:A:G | - | 0.102488140463283 | 0.00545117551646823 | SARC | Female-baised eQTL |
| rs1948461 | chr12:44443462:C:T | - | 0.102488140463283 | 0.00545117551646823 | SARC | Female-baised eQTL |
| rs76158394 | chr12:44375018:T:C | - | 0.102435116629465 | 0.00547233212741111 | SARC | Female-baised eQTL |
| rs17121314 | chr12:44378519:A:C | - | 0.102435116629465 | 0.00547233212741111 | SARC | Female-baised eQTL |
| rs73087664 | chr12:44013454:C:G | - | 0.0982149891302298 | 0.00551213884465895 | SARC | Female-baised eQTL |
| rs73091741 | chr12:44063011:A:C | - | 0.0982149891302298 | 0.00551213884465895 | SARC | Female-baised eQTL |
| rs76787060 | chr12:44366448:A:G | - | 0.102135085796064 | 0.0058518317625862 | SARC | Female-baised eQTL |
| rs77562372 | chr12:46800905:C:T | - | 0.0973489685182807 | 0.00664355872569719 | SARC | Female-baised eQTL |
| rs17666239 | chr12:46800974:T:A | - | 0.0973489685182807 | 0.00664355872569719 | SARC | Female-baised eQTL |
| rs78803796 | chr12:46801273:G:C | - | 0.0973489685182807 | 0.00664355872569719 | SARC | Female-baised eQTL |
| rs78021259 | chr12:46801408:G:A | - | 0.0973489685182807 | 0.00664355872569719 | SARC | Female-baised eQTL |
| rs78196330 | chr12:46801632:A:G | - | 0.0973489685182807 | 0.00664355872569719 | SARC | Female-baised eQTL |
| rs76447333 | chr12:46802848:A:G | - | 0.0973489685182807 | 0.00664355872569719 | SARC | Female-baised eQTL |
| rs77721949 | chr12:46804056:T:C | - | 0.0973489685182807 | 0.00664355872569719 | SARC | Female-baised eQTL |
| rs113674212 | chr12:46805073:C:A | - | 0.0972040318410828 | 0.00677451988921945 | SARC | Female-baised eQTL |
| rs79020793 | chr12:46805766:G:A | - | 0.0972040318410828 | 0.00677451988921945 | SARC | Female-baised eQTL |
| rs75017413 | chr12:46805868:T:A | - | 0.0972040318410828 | 0.00677451988921945 | SARC | Female-baised eQTL |
| rs79295634 | chr12:46786225:A:G | - | 0.0952603134997485 | 0.00714737436923291 | SARC | Female-baised eQTL |
| rs7955106 | chr12:44384812:G:C | - | 0.0972109742456737 | 0.00948105605883445 | SARC | Female-baised eQTL |
| rs74085177 | chr12:44394795:T:C | - | 0.09351349714552 | 0.0133851355438092 | SARC | Female-baised eQTL |
| rs74085178 | chr12:44394796:C:T | - | 0.09351349714552 | 0.0133851355438092 | SARC | Female-baised eQTL |
| rs57673436 | chr12:44395584:A:G | - | 0.09351349714552 | 0.0133851355438092 | SARC | Female-baised eQTL |
| rs11170112 | chr12:52394255:A:G | - | 0.0893561287569546 | 0.0145371334219957 | SARC | Female-baised eQTL |
| rs34881657 | chr12:46901666:A:G | - | 0.084462865156672 | 0.0171668189159323 | SARC | Female-baised eQTL |
| rs113965099 | chr12:46842598:G:T | - | 0.0827219902274137 | 0.0183397273274587 | SARC | Female-baised eQTL |
| rs77779784 | chr12:46836163:G:A | - | 0.0827028042514663 | 0.0184770054262218 | SARC | Female-baised eQTL |
| rs113446023 | chr12:46836226:T:C | - | 0.0827028042514663 | 0.0184770054262218 | SARC | Female-baised eQTL |
| rs79515995 | chr12:46837498:A:G | - | 0.0827028042514663 | 0.0184770054262218 | SARC | Female-baised eQTL |
| rs76021225 | chr12:46839110:A:G | - | 0.0827028042514663 | 0.0184770054262218 | SARC | Female-baised eQTL |
| rs17094615 | chr12:44407844:C:T | - | 0.0893474935140505 | 0.0192247494606727 | SARC | Female-baised eQTL |
| rs80156386 | chr12:46883676:A:T | - | 0.081657077610679 | 0.022282461680509 | SARC | Female-baised eQTL |
| rs74082963 | chr12:46886018:G:A | - | 0.081657077610679 | 0.022282461680509 | SARC | Female-baised eQTL |
| rs74082966 | chr12:46887292:G:C | - | 0.081657077610679 | 0.022282461680509 | SARC | Female-baised eQTL |
| rs76735417 | chr12:46888649:C:A | - | 0.081657077610679 | 0.022282461680509 | SARC | Female-baised eQTL |
| rs74723369 | chr12:46891418:G:A | - | 0.0816691725193973 | 0.0225630092097548 | SARC | Female-baised eQTL |
| rs35024790 | chr12:46893914:T:C | - | 0.0815159412519257 | 0.0230534791651031 | SARC | Female-baised eQTL |
| rs12822229 | chr12:62010167:C:T | - | 0.0826793174305485 | 0.0236439060815377 | SARC | Female-baised eQTL |
| rs34004360 | chr12:62012573:T:C | - | 0.0826793174305485 | 0.0236439060815377 | SARC | Female-baised eQTL |
| rs146643528 | chr12:46849204:A:G | - | 0.0796168018700718 | 0.0257732523208069 | SARC | Female-baised eQTL |
| rs141178469 | chr12:46850595:G:C | - | 0.0796168018700718 | 0.0257732523208069 | SARC | Female-baised eQTL |
| rs149541696 | chr12:46850768:G:T | - | 0.0796168018700718 | 0.0257732523208069 | SARC | Female-baised eQTL |
| rs71462931 | chr12:46854261:T:C | - | 0.0796168018700718 | 0.0257732523208069 | SARC | Female-baised eQTL |
| rs7980196 | chr12:46857681:G:C | - | 0.0796168018700718 | 0.0257732523208069 | SARC | Female-baised eQTL |
| rs79897568 | chr12:46859961:G:A | - | 0.0796168018700718 | 0.0257732523208069 | SARC | Female-baised eQTL |
| rs77791373 | chr12:46860444:C:T | - | 0.0796168018700718 | 0.0257732523208069 | SARC | Female-baised eQTL |
| rs75408153 | chr12:46862222:G:T | - | 0.0796168018700718 | 0.0257732523208069 | SARC | Female-baised eQTL |
| rs77820945 | chr12:46862594:G:A | - | 0.0796168018700718 | 0.0257732523208069 | SARC | Female-baised eQTL |
| rs111724108 | chr12:46864049:G:A | - | 0.0796168018700718 | 0.0257732523208069 | SARC | Female-baised eQTL |
| rs79779502 | chr12:46865285:G:A | - | 0.0796168018700718 | 0.0257732523208069 | SARC | Female-baised eQTL |
| rs113290905 | chr12:46865740:A:G | - | 0.0796168018700718 | 0.0257732523208069 | SARC | Female-baised eQTL |
| rs7310091 | chr12:46866229:G:T | - | 0.0796168018700718 | 0.0257732523208069 | SARC | Female-baised eQTL |
| rs7132156 | chr12:46870964:A:C | - | 0.0796168018700718 | 0.0257732523208069 | SARC | Female-baised eQTL |
| rs74321169 | chr12:46874228:C:T | - | 0.0796168018700718 | 0.0257732523208069 | SARC | Female-baised eQTL |
| rs74082953 | chr12:46875478:T:C | - | 0.0796168018700718 | 0.0257732523208069 | SARC | Female-baised eQTL |
| rs143420411 | chr12:46880228:A:G | - | 0.0796168018700718 | 0.0257732523208069 | SARC | Female-baised eQTL |
| rs117191892 | chr12:46882855:G:T | - | 0.0796168018700718 | 0.0257732523208069 | SARC | Female-baised eQTL |
| rs782119 | chr12:58450202:T:C | - | -0.076034601884971 | 0.0260903500617445 | SARC | Female-baised eQTL |
| rs34666797 | chr12:46902335:A:G | - | 0.0786898191485171 | 0.0306468196836184 | SARC | Female-baised eQTL |
| rs12810051 | chr12:46903433:G:A | - | 0.0786898191485171 | 0.0306468196836184 | SARC | Female-baised eQTL |
| rs12813857 | chr12:46906545:T:C | - | 0.0786898191485171 | 0.0306468196836184 | SARC | Female-baised eQTL |
| rs11837530 | chr12:58463318:C:A | - | 0.0739979980456859 | 0.0316796773057303 | SARC | Female-baised eQTL |
| rs71465130 | chr12:62073205:C:T | - | 0.0790002963421412 | 0.0352232973953301 | SARC | Female-baised eQTL |
| rs76792262 | chr12:46890923:G:T | - | 0.0759866504867322 | 0.0411341012146473 | SARC | Female-baised eQTL |
| rs12832186 | chr12:46906392:A:T | - | 0.0758436792890809 | 0.0415761737974507 | SARC | Female-baised eQTL |
| rs74082948 | chr12:46873264:G:C | - | 0.0733267508366696 | 0.0451929605445997 | SARC | Female-baised eQTL |
| rs75990735 | chr12:49837885:A:C | - | 0.216893635910015 | 0.0316558496028777 | LUSC | Female-baised eQTL |
| rs7305296 | chr12:44202768:T:C | - | 0.153658881159683 | 0.0113918805498358 | KIRC | Female-baised eQTL |
| rs73100835 | chr12:44206057:A:G | - | 0.153624855285193 | 0.0113918805498358 | KIRC | Female-baised eQTL |
| rs73100838 | chr12:44206523:T:C | - | 0.153624855285193 | 0.0113918805498358 | KIRC | Female-baised eQTL |
| rs73100851 | chr12:44214303:G:A | - | 0.153624855285193 | 0.0113918805498358 | KIRC | Female-baised eQTL |
| rs7311937 | chr12:44224225:C:A | - | 0.153624855285193 | 0.0113918805498358 | KIRC | Female-baised eQTL |
| rs73102952 | chr12:44236958:T:C | - | 0.153624855285193 | 0.0113918805498358 | KIRC | Female-baised eQTL |
| rs73102953 | chr12:44237679:C:T | - | 0.153624855285193 | 0.0113918805498358 | KIRC | Female-baised eQTL |
| rs73102954 | chr12:44237860:A:G | - | 0.153624855285193 | 0.0113918805498358 | KIRC | Female-baised eQTL |
| rs17094343 | chr12:44247914:C:A | - | 0.153624855285193 | 0.0113918805498358 | KIRC | Female-baised eQTL |
| rs55840982 | chr12:44254046:C:T | - | 0.153624855285193 | 0.0113918805498358 | KIRC | Female-baised eQTL |
| rs7313649 | chr12:44257575:T:A | - | 0.153624855285193 | 0.0113918805498358 | KIRC | Female-baised eQTL |
| rs17094356 | chr12:44259892:A:C | - | 0.153624855285193 | 0.0113918805498358 | KIRC | Female-baised eQTL |
| rs79931431 | chr12:44275831:G:T | - | 0.153624855285193 | 0.0113918805498358 | KIRC | Female-baised eQTL |
| rs57851938 | chr12:44280497:G:T | - | 0.153624855285193 | 0.0113918805498358 | KIRC | Female-baised eQTL |
| rs58602576 | chr12:44095245:T:C | - | 0.132658448884582 | 0.0380083704796858 | KIRC | Female-baised eQTL |
| rs113825270 | chr12:44097721:G:C | - | 0.132658448884582 | 0.0380083704796858 | KIRC | Female-baised eQTL |
| rs73093451 | chr12:44100767:G:T | - | 0.132658448884582 | 0.0380083704796858 | KIRC | Female-baised eQTL |
| rs77945678 | chr12:44115405:T:A | - | 0.132658448884582 | 0.0380083704796858 | KIRC | Female-baised eQTL |
| rs73093490 | chr12:44125064:T:C | - | 0.132658448884582 | 0.0380083704796858 | KIRC | Female-baised eQTL |
| rs73093494 | chr12:44126505:T:C | - | 0.132658448884582 | 0.0380083704796858 | KIRC | Female-baised eQTL |
| rs7968824 | chr12:44169632:C:T | - | 0.132658448884582 | 0.0380083704796858 | KIRC | Female-baised eQTL |
| rs367735204 | chr12:44113983:G:A | - | 0.0886723557143336 | 0.04717848735965 | KIRC | Female-baised eQTL |
| Female-specific eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Effect Score | FDR | Cancer Type | Biased Type |
| rs12828184 | chr12:58078310:C:G | - | 0.0613912877189507 | 0.0265015718046585 | HNSC | Male-baised eQTL |
| rs11832013 | chr12:58775597:C:T | - | 0.0859789004936518 | 0.000128509494532247 | KIRC | Male-baised eQTL |
| rs11182294 | chr12:43837736:C:T | - | 0.0752785798882645 | 0.00020305307212252 | KIRC | Male-baised eQTL |
| rs747906 | chr12:56839566:C:G | - | 0.0659012288229268 | 0.00502761437171404 | KIRC | Male-baised eQTL |
| rs1078043 | chr12:56839052:A:G | - | 0.0671195173042629 | 0.00853946905706733 | KIRC | Male-baised eQTL |
| rs57340110 | chr12:56835596:A:G | - | 0.0674855610619836 | 0.00952457847313332 | KIRC | Male-baised eQTL |
| rs11829130 | chr12:56833391:T:C | - | 0.0645936033944538 | 0.0125618936979866 | KIRC | Male-baised eQTL |
| rs7305383 | chr12:56833972:G:C | - | 0.0645936033944538 | 0.0125618936979866 | KIRC | Male-baised eQTL |
| rs7305808 | chr12:56834433:C:T | - | 0.0645936033944538 | 0.0125618936979866 | KIRC | Male-baised eQTL |
| rs10506233 | chr12:43982228:A:C | - | 0.0857239012444487 | 0.0222873623752179 | KIRC | Male-baised eQTL |
| rs10876044 | chr12:50512622:C:T | - | -0.0353454304830922 | 0.0257804060807316 | KIRC | Male-baised eQTL |
| rs11614911 | chr12:50511385:G:A | - | -0.0348282653824965 | 0.0298759269238823 | KIRC | Male-baised eQTL |
| rs10783367 | chr12:50521653:G:A | - | -0.0345550557235825 | 0.0304876161118006 | KIRC | Male-baised eQTL |
| rs7308872 | chr12:50726391:T:C | - | -0.0345188578218852 | 0.0307749502337463 | KIRC | Male-baised eQTL |
| rs4768885 | chr12:50527989:G:A | - | -0.0344985275158368 | 0.0310100246919369 | KIRC | Male-baised eQTL |
| rs4768886 | chr12:50528196:G:A | - | -0.0344985275158368 | 0.0310100246919369 | KIRC | Male-baised eQTL |
| rs11182287 | chr12:43824736:T:C | - | 0.0663463520810811 | 0.0340895094057334 | KIRC | Male-baised eQTL |
| rs73098836 | chr12:43892450:G:A | - | 0.0549131161328737 | 0.0341480454979847 | KIRC | Male-baised eQTL |
| rs7958314 | chr12:43908627:G:T | - | 0.0547188838909978 | 0.0353929507340291 | KIRC | Male-baised eQTL |
| rs7957146 | chr12:43912956:C:G | - | 0.0547188838909978 | 0.0353929507340291 | KIRC | Male-baised eQTL |
| rs7970701 | chr12:56929604:C:G | - | 0.0395642796395377 | 0.0443277428423365 | KIRC | Male-baised eQTL |
| rs11834543 | chr12:49224260:T:C | - | 0.0459831289802676 | 0.0486121287505641 | KIRC | Male-baised eQTL |
| rs1976823 | chr12:54552063:T:C | - | -0.0814824479864961 | 0.00233674866504372 | BLCA | Male-baised eQTL |
| rs12309572 | chr12:53680902:C:T | - | 0.0649792505906371 | 0.00965142485167333 | BLCA | Male-baised eQTL |
| rs6580903 | chr12:52770753:C:A | - | -0.101465818427159 | 0.0145062121286767 | BLCA | Male-baised eQTL |
| rs4759286 | chr12:53686236:A:C | - | 0.0621117120191382 | 0.0149780718971188 | BLCA | Male-baised eQTL |
| rs11170633 | chr12:53655149:A:G | - | 0.0634519420798901 | 0.0151624340625268 | BLCA | Male-baised eQTL |
| rs6580902 | chr12:52770405:A:C | - | -0.09888960683241 | 0.0179515431923119 | BLCA | Male-baised eQTL |
| rs7308435 | chr12:54554999:T:C | - | -0.0708157847384116 | 0.0180133676809699 | BLCA | Male-baised eQTL |
| rs11830069 | chr12:53650409:T:C | - | 0.0624943929547349 | 0.0212744211779646 | BLCA | Male-baised eQTL |
| rs7304578 | chr12:51275949:C:T | - | -0.0577277069811417 | 0.0213700617331311 | BLCA | Male-baised eQTL |
| rs7296747 | chr12:51272745:T:C | - | -0.05743380428764 | 0.0232856100624456 | BLCA | Male-baised eQTL |
| rs10783591 | chr12:53642612:T:C | - | 0.0613010366512128 | 0.0262270884806016 | BLCA | Male-baised eQTL |
| rs2271821 | chr12:51270363:A:G | - | -0.0558466892677518 | 0.0288154953370984 | BLCA | Male-baised eQTL |
| rs10876472 | chr12:53638509:C:T | - | 0.0602880555136442 | 0.0312703659631742 | BLCA | Male-baised eQTL |
| rs11170629 | chr12:53640365:C:G | - | 0.0602880555136442 | 0.0312703659631742 | BLCA | Male-baised eQTL |
| rs10876473 | chr12:53640790:C:T | - | 0.0602880555136442 | 0.0312703659631742 | BLCA | Male-baised eQTL |
| rs2365341 | chr12:53641448:A:C | - | 0.0602880555136442 | 0.0312703659631742 | BLCA | Male-baised eQTL |
| rs10783593 | chr12:53643709:C:T | - | 0.0601625394865949 | 0.0317132413843148 | BLCA | Male-baised eQTL |
| rs12314877 | chr12:53648165:G:A | - | 0.0601632759567399 | 0.0322670520002642 | BLCA | Male-baised eQTL |
| rs4761935 | chr12:51257372:G:A | - | -0.0526727188994329 | 0.0361142866842028 | BLCA | Male-baised eQTL |
| rs1877261 | chr12:51263852:T:C | - | -0.0546813071983946 | 0.0367470595994987 | BLCA | Male-baised eQTL |
| rs3951438 | chr12:51264825:A:G | - | -0.0545678519094043 | 0.0378741199650453 | BLCA | Male-baised eQTL |
| rs10783427 | chr12:51264956:A:G | - | -0.0545678519094043 | 0.0378741199650453 | BLCA | Male-baised eQTL |
| rs4761814 | chr12:51262837:A:G | - | -0.0542246406889459 | 0.0396545008807579 | BLCA | Male-baised eQTL |
| rs4146339 | chr12:48444286:A:G | - | 0.0668283590912349 | 0.0398571376891139 | BLCA | Male-baised eQTL |
| rs10783428 | chr12:51265304:T:C | - | -0.0519770921334166 | 0.0404472395010919 | BLCA | Male-baised eQTL |
| rs7957707 | chr12:52236699:C:T | gene,enhancer | 0.0772529486600009 | 0.0404690752422519 | BLCA | Male-baised eQTL |
| rs113050287 | chr12:48445029:G:A | - | 0.066654633734587 | 0.040770529452178 | BLCA | Male-baised eQTL |
| rs115929187 | chr12:48451300:A:T | - | 0.066654633734587 | 0.040770529452178 | BLCA | Male-baised eQTL |
| rs11835510 | chr12:48451694:A:C | - | 0.066654633734587 | 0.040770529452178 | BLCA | Male-baised eQTL |
| rs4554933 | chr12:48452480:C:A | - | 0.066654633734587 | 0.040770529452178 | BLCA | Male-baised eQTL |
| rs4761995 | chr12:51286080:G:A | - | -0.0548599576717843 | 0.0420376327794154 | BLCA | Male-baised eQTL |
| rs12423516 | chr12:48457658:C:T | - | 0.0666027751942432 | 0.0421348804255159 | BLCA | Male-baised eQTL |
| rs11612896 | chr12:48458599:T:C | - | 0.0666027751942432 | 0.0421348804255159 | BLCA | Male-baised eQTL |
| rs12297408 | chr12:53628777:G:T | - | 0.0581751775746175 | 0.0423469882952325 | BLCA | Male-baised eQTL |
| rs10431542 | chr12:53629005:T:C | - | 0.0581751775746175 | 0.0423469882952325 | BLCA | Male-baised eQTL |
| rs11168584 | chr12:48459795:C:A | - | 0.0664143038138921 | 0.0434413498721129 | BLCA | Male-baised eQTL |
| rs2884709 | chr12:51260462:C:T | - | -0.0537886761951559 | 0.0438026115442364 | BLCA | Male-baised eQTL |
| rs56796388 | chr12:48458441:C:T | - | 0.0662515681917941 | 0.0444815593405704 | BLCA | Male-baised eQTL |
| rs4761938 | chr12:51258606:A:G | - | -0.052695809255399 | 0.0445732575448898 | BLCA | Male-baised eQTL |
| rs4991750 | chr12:51287593:G:A | - | -0.0541659910884383 | 0.0471716031918922 | BLCA | Male-baised eQTL |
| rs1506848 | chr12:61687977:A:C | - | -0.0466808456714563 | 0.000445164928638014 | COAD | Male-baised eQTL |
| rs10784246 | chr12:61661840:T:C | - | -0.0459605536659625 | 0.000526249548337234 | COAD | Male-baised eQTL |
| rs1605325 | chr12:61668057:T:C | - | -0.0459605536659625 | 0.000526249548337234 | COAD | Male-baised eQTL |
| rs4310677 | chr12:61670817:G:T | - | -0.0459605536659625 | 0.000526249548337234 | COAD | Male-baised eQTL |
| rs7973591 | chr12:61674945:T:A | - | -0.0459605536659625 | 0.000526249548337234 | COAD | Male-baised eQTL |
| rs7296609 | chr12:61617956:A:G | - | -0.0455652413314494 | 0.000586390084531285 | COAD | Male-baised eQTL |
| rs6581426 | chr12:61751979:T:C | - | -0.0465444352236122 | 0.000680392323696034 | COAD | Male-baised eQTL |
| rs1605326 | chr12:61635311:C:T | - | -0.0451371007393396 | 0.0007013169843712 | COAD | Male-baised eQTL |
| rs2084998 | chr12:61621624:A:G | - | -0.04475755813215 | 0.000777296397333241 | COAD | Male-baised eQTL |
| rs7487386 | chr12:61750544:G:C | - | -0.0447533555748176 | 0.00118978162234204 | COAD | Male-baised eQTL |
| rs7974958 | chr12:61753137:T:C | - | -0.0447533555748176 | 0.00118978162234204 | COAD | Male-baised eQTL |
| rs6581430 | chr12:61766297:T:C | - | -0.0393410081647842 | 0.0150567201135161 | COAD | Male-baised eQTL |
| rs1395489 | chr12:61654697:A:G | - | -0.0328697519619946 | 0.0151039790612382 | COAD | Male-baised eQTL |
| Opposite sex-biased eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Male Effect | Male FDR | Female Effect | Female FDR | Sex-biased Gene in Cancer | Cancer Type |
Top |
Sex-biased eQTM regulation of gene |
| Sex-biased eQTM regulation of gene (The figures only show the pairs with FDR<1e-5. For more information please check the below table). |
| eQTM | Description |
 | Gene ID: ENSG00000135480 |
| CpG Site: cg25029197 | |
| Position to Gene: gene,exon | |
| Male Effect: -0.519744998181303 | |
| Female Effect: - | |
 | Gene ID: ENSG00000135480 |
| CpG Site: cg25313172 | |
| Position to Gene: gene,exon,CDS,promoter | |
| Male Effect: - | |
| Female Effect: -0.346033043921944 | |
 | Gene ID: ENSG00000135480 |
| CpG Site: cg03434950 | |
| Position to Gene: gene | |
| Male Effect: - | |
| Female Effect: -0.484920772681098 |
| Male-specific eQTM regulation. |
| CpG Site | CpG Postion | Position to Gene | Effect Score | FDR | Cor.r | Cor.Pvalue | Cancer Type |
| cg25029197 | chr12:52245412 | gene,exon | -0.519744998181303 | 2.41067731812306e-05 | -0.5481451289885171 | 1.099823328164282e-10 | SARC |
| Female-specific eQTM regulation. |
| CpG Site | CpG Postion | Position to Gene | Effect Score | FDR | Cor.r | Cor.Pvalue | Cancer Type |
| cg25313172 | chr12:52233488 | gene,exon,CDS,promoter | -0.346033043921944 | 6.72705014960758e-05 | -0.43193909185958473 | 4.690207261863094e-08 | COAD |
| cg03434950 | chr12:52237721 | gene | -0.484920772681098 | 4.71494497988708e-08 | -0.6431072423541192 | 8.504662748147522e-10 | KIRP |
| Opposite sex-biased eQTM regulation. |
| CpG Site | CpG Postion | CpG Island | Position to Gene | Male Effect | Male FDR | Female Effect | Female FDR | Male Cor | Male P-value | Female Cor | Female P-value | Sex-biased Coding Gene | Cancer Type |
Top |
Sex-biased sQTL regulation of gene |
| Sex-biased sQTL regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| sQTL | Description |
| Male-specific sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Effect Score | FDR | Cancer Type | Biased Type |
| Female-specific sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Effect Score | FDR | Cancer Type | Biased Type |
| Opposite sex-biased sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Male Effect | Male FDR | Female Effect | Female FDR | Cancer Type |
Top |
Sex-biased sQTM regulation of gene |
| Sex-biased sQTM regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| sQTM | Description |
| Male-specific sQTM regulation. |
| EX ID | Skipped Exon | CPG Site | CPG Position | Position to EX Events | Effect Score | FDR | Cor.r | Cor.Pvalue | ORF_anno | Cancer Type |
| Female-specific sQTM regulation. |
| EX ID | Skipped Exon | CPG Site | CPG Position | Position to EX Events | Effect Score | FDR | Cor.r | Cor.Pvalue | ORF_anno | Cancer Type |
| Opposite sex-biased sQTM regulation. |
| EX ID | EX Info | Skipped Exon | CPG Site | CPG Position | CPG Island | Position to EX Events | Male Effect | Male FDR | Female Effect | Female FDR | Male Correlation | Male P-value | Female Correlation | Female P-value | ORF_anno | Cancer Type |
Top |
Related disease information of KRT7 |
| Diseases associated with this gene (DisGeNET). |
| Gene ID | Gene Symbol | Disease ID | Disease Name | Number of PMID | Source |
| ENSG00000135480 | KRT7 | C0007134 | Renal Cell Carcinoma | 2 | CTD_human |
| ENSG00000135480 | KRT7 | C0008312 | Primary biliary cirrhosis | 1 | CTD_human |
| ENSG00000135480 | KRT7 | C0019189 | Hepatitis, Chronic | 1 | CTD_human |
| ENSG00000135480 | KRT7 | C0023892 | Biliary cirrhosis | 1 | CTD_human |
| ENSG00000135480 | KRT7 | C0027626 | Neoplasm Invasiveness | 1 | CTD_human |
| ENSG00000135480 | KRT7 | C0149519 | Chronic Persistent Hepatitis | 1 | CTD_human |
| ENSG00000135480 | KRT7 | C0238065 | Secondary Biliary Cholangitis | 1 | CTD_human |
| ENSG00000135480 | KRT7 | C0279702 | Conventional (Clear Cell) Renal Cell Carcinoma | 2 | CTD_human |
| ENSG00000135480 | KRT7 | C0520463 | Chronic active hepatitis | 1 | CTD_human |
| ENSG00000135480 | KRT7 | C0524611 | Cryptogenic Chronic Hepatitis | 1 | CTD_human |
| ENSG00000135480 | KRT7 | C0949541 | Hurthle Cell Tumor | 1 | CTD_human |
| ENSG00000135480 | KRT7 | C1266042 | Chromophobe Renal Cell Carcinoma | 2 | CTD_human |
| ENSG00000135480 | KRT7 | C1266043 | Sarcomatoid Renal Cell Carcinoma | 2 | CTD_human |
| ENSG00000135480 | KRT7 | C1266044 | Collecting Duct Carcinoma of the Kidney | 2 | CTD_human |
| ENSG00000135480 | KRT7 | C1306837 | Papillary Renal Cell Carcinoma | 2 | CTD_human |
| ENSG00000135480 | KRT7 | C1510502 | Oxyphilic Adenoma | 1 | CTD_human |
| ENSG00000135480 | KRT7 | C1876165 | Copper-Overload Cirrhosis | 1 | CTD_human |
| ENSG00000135480 | KRT7 | C4551595 | Biliary Cirrhosis, Primary, 1 | 1 | CTD_human |
